Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

10.10
BATS BZX Real-Time Price
As of 11:16am ET
 -0.10 / -0.98%
Today’s Change
7.02
Today|||52-Week Range
13.46
-16.53%
Year-to-Date
Pluristem (PSTI) Intermittent Claudication Study Enrolled
Jan 13 / Zacks.com - Paid Partner Content
Emergent Down on '17 View, Posts Preliminary '16 Results
Jan 10 / Zacks.com - Paid Partner Content
TherapeuticsMD's Rejoice Study Data Published in Journal
Jan 12 / Zacks.com - Paid Partner Content
AbbVie's HCV Combo Favorable in Japanese Phase III Study
Jan 10 / Zacks.com - Paid Partner Content
Gilead (GILD) HBV Drug Vemlidy Receives European Approval
Jan 12 / Zacks.com - Paid Partner Content
Celgene Issues Preliminary 2016 Results, Lifts 2017 View
Jan 10 / Zacks.com - Paid Partner Content
Alexion (ALXN) Files for Label Expansion of Soliris in U.S., EU
Jan 11 / Zacks.com - Paid Partner Content
Puma (PBYI) Expands Study Cohort for Lead Candidate PB272
Jan 09 / Zacks.com - Paid Partner Content
Sanofi, ImmuNext Ink Deal, Focus on Autoimmune Diseases
Jan 11 / Zacks.com - Paid Partner Content
Alexion Blood Disorder Drug Gets Orphan Designation in U.S.
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close10.20
Today’s open10.10
Day’s range9.95 - 10.10
Volume2,400
Average volume (3 months)344,991
Market cap$591.7M
Dividend yield--
Data as of 11:16am ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-98.80%
Earnings growth (this year)+40.95%
Earnings growth (next 5 years)--
Revenue growth (last year)-93.82%
P/E ratioNM
Price/Sales249.31
Price/Book2.51

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd-0.05-0.22%
ANIPANI Pharmaceuticals ...-0.18-0.32%
NKNantKwest Inc+0.05+0.78%
EDITEditas Medicine Inc+0.32+1.76%
Data as of 11:17am ET, 01/20/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$2.6M
Annual profit (last year)-$132.4M
Net profit margin-5,170.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs